To elucidate the molecular mechanisms by which MRPS7 and MRPS23 drive NPC progression, we performed co-IP combined with mass spectrometry to identify potential regulatory partners of MRPS7 and MRPS23. Here, MRPS23 is linked to nasopharyngeal carcinoma.